Literature DB >> 24606845

Review of the clinical and biologic aspects of human papillomavirus-positive squamous cell carcinomas of the head and neck.

Grace C Blitzer1, Molly A Smith1, Stephen L Harris2, Randall J Kimple3.   

Abstract

Human papillomavirus (HPV), a known etiology of a subset of head-and-neck squamous cell carcinomas (HNCs), causes numerous alterations in normal cellular functions. This article reviews the biology, detection, and treatment of HPV-positive HNC. The role of HPV oncoproteins in tumor development, the natural history of HPV infection, and risk factors for and prevention of transmission of oral HPV are considered. Commonly used methods for detecting HPV infection, including limitations of these methods, are discussed to aid the practicing clinician in using these tests in their clinical practice. Clinical characteristics of HPV-positive HNC, including potential explanations for the improved outcomes seen in patients with HPV-positive HNC, are assessed. Ongoing clinical trials specific for patients with HPV-positive HNC are described, and areas in need of additional research are summarized. Until the results of ongoing trials are known, treatment of HPV-positive HNC should not differ in clinical practice from treatment of similar non-HPV related cancers.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2014        PMID: 24606845      PMCID: PMC3990872          DOI: 10.1016/j.ijrobp.2013.08.029

Source DB:  PubMed          Journal:  Int J Radiat Oncol Biol Phys        ISSN: 0360-3016            Impact factor:   7.038


  87 in total

Review 1.  Mechanisms of cell transformation by papillomavirus E5 proteins.

Authors:  D DiMaio; D Mattoon
Journal:  Oncogene       Date:  2001-11-26       Impact factor: 9.867

2.  High-risk human papillomavirus affects prognosis in patients with surgically treated oropharyngeal squamous cell carcinoma.

Authors:  Lisa Licitra; Federica Perrone; Paolo Bossi; Simona Suardi; Luigi Mariani; Raffaella Artusi; Maria Oggionni; Chiara Rossini; Giulio Cantù; Massimo Squadrelli; Pasquale Quattrone; Laura D Locati; Cristiana Bergamini; Patrizia Olmi; Marco A Pierotti; Silvana Pilotti
Journal:  J Clin Oncol       Date:  2006-12-20       Impact factor: 44.544

3.  Radiation-induced loss of cell surface CD47 enhances immune-mediated clearance of human papillomavirus-positive cancer.

Authors:  Daniel W Vermeer; William C Spanos; Paola D Vermeer; Annie M Bruns; Kimberly M Lee; John H Lee
Journal:  Int J Cancer       Date:  2013-02-12       Impact factor: 7.396

4.  Evaluation of human papilloma virus diagnostic testing in oropharyngeal squamous cell carcinoma: sensitivity, specificity, and prognostic discrimination.

Authors:  Andrew G Schache; Triantafilos Liloglou; Janet M Risk; Anastasia Filia; Terence M Jones; Jon Sheard; Julia A Woolgar; Timothy R Helliwell; Asterios Triantafyllou; Max Robinson; Philip Sloan; Colin Harvey-Woodworth; Daniel Sisson; Richard J Shaw
Journal:  Clin Cancer Res       Date:  2011-10-01       Impact factor: 12.531

5.  The human papillomavirus type 16 E6 and E7 oncoproteins cooperate to induce mitotic defects and genomic instability by uncoupling centrosome duplication from the cell division cycle.

Authors:  S Duensing; L Y Lee; A Duensing; J Basile; S Piboonniyom; S Gonzalez; C P Crum; K Munger
Journal:  Proc Natl Acad Sci U S A       Date:  2000-08-29       Impact factor: 11.205

6.  Combined analysis of HPV-DNA, p16 and EGFR expression to predict prognosis in oropharyngeal cancer.

Authors:  Niklas Reimers; Hans U Kasper; Soenke J Weissenborn; Hartmut Stützer; Simon F Preuss; Thomas K Hoffmann; Ernst Jan M Speel; Hans P Dienes; Herbert J Pfister; Orlando Guntinas-Lichius; Jens P Klussmann
Journal:  Int J Cancer       Date:  2007-04-15       Impact factor: 7.396

7.  Human papillomavirus E7 induces rereplication in response to DNA damage.

Authors:  Xueli Fan; Yingwang Liu; Susan A Heilman; Jason J Chen
Journal:  J Virol       Date:  2012-11-14       Impact factor: 5.103

8.  Role of human papillomavirus genotype in prognosis of early-stage cervical cancer undergoing primary surgery.

Authors:  Chyong-Huey Lai; Chee-Jen Chang; Huei-Jean Huang; Swei Hsueh; Angel Chao; Jung-Erh Yang; Cheng-Tao Lin; Shang-Lang Huang; Ji-Hong Hong; Hung-Hsueh Chou; Tzu-I Wu; Kuan-Gen Huang; Chun-Chieh Wang; Ting-Chang Chang
Journal:  J Clin Oncol       Date:  2007-08-20       Impact factor: 44.544

9.  Effector memory T-cell frequencies in relation to tumour stage, location and HPV status in HNSCC patients.

Authors:  A W Turksma; H J Bontkes; H van den Heuvel; T D de Gruijl; B M E von Blomberg; B J M Braakhuis; C R Leemans; E Bloemena; C J L M Meijer; E Hooijberg
Journal:  Oral Dis       Date:  2012-11-26       Impact factor: 3.511

10.  PD-1-expressing tumor-infiltrating T cells are a favorable prognostic biomarker in HPV-associated head and neck cancer.

Authors:  Cécile Badoual; Stéphane Hans; Nathalie Merillon; Cordélia Van Ryswick; Patrice Ravel; Nadine Benhamouda; Emeline Levionnois; Mevyn Nizard; Ali Si-Mohamed; Nicolas Besnier; Alain Gey; Rinat Rotem-Yehudar; Hélène Pere; Thi Tran; Coralie L Guerin; Anne Chauvat; Estelle Dransart; Cécile Alanio; Sebastien Albert; Beatrix Barry; Federico Sandoval; Françoise Quintin-Colonna; Patrick Bruneval; Wolf H Fridman; Francois M Lemoine; Stephane Oudard; Ludger Johannes; Daniel Olive; Daniel Brasnu; Eric Tartour
Journal:  Cancer Res       Date:  2012-11-07       Impact factor: 12.701

View more
  35 in total

1.  Human papilloma virus load and PD-1/PD-L1, CD8+ and FOXP3 in anal cancer patients treated with chemoradiotherapy: Rationale for immunotherapy.

Authors:  Panagiotis Balermpas; Daniel Martin; Ulrike Wieland; Margret Rave-Fränk; Klaus Strebhardt; Claus Rödel; Emmanouil Fokas; Franz Rödel
Journal:  Oncoimmunology       Date:  2017-02-06       Impact factor: 8.110

2.  Team-Based Learning Module for Undergraduate Medical Education: a Module Focused on the Human Papilloma Virus to Increase Willingness to Vaccinate.

Authors:  Rachel Wiley; Zeena Shelal; Carolyn Bernard; Diana Urbauer; Eugene Toy; Lois Ramondetta
Journal:  J Cancer Educ       Date:  2019-04       Impact factor: 2.037

3.  Phase II Evaluation of Aggressive Dose De-Escalation for Adjuvant Chemoradiotherapy in Human Papillomavirus-Associated Oropharynx Squamous Cell Carcinoma.

Authors:  Daniel J Ma; Katharine A Price; Eric J Moore; Samir H Patel; Michael L Hinni; Joaquin J Garcia; Darlene E Graner; Nathan R Foster; Brenda Ginos; Michelle Neben-Wittich; Yolanda I Garces; Ashish V Chintakuntlawar; Daniel L Price; Kerry D Olsen; Kathryn M Van Abel; Jan L Kasperbauer; Jeffrey R Janus; Mark Waddle; Robert Miller; Satomi Shiraishi; Robert L Foote
Journal:  J Clin Oncol       Date:  2019-06-04       Impact factor: 44.544

4.  Incidence and prognostic impact of high-risk HPV tumor infection in cervical esophageal carcinoma.

Authors:  Ethan B Ludmir; Manisha Palta; Xuefeng Zhang; Yuan Wu; Christopher G Willett; Brian G Czito
Journal:  J Gastrointest Oncol       Date:  2014-12

Review 5.  Human papillomavirus tumor infection in esophageal squamous cell carcinoma.

Authors:  Ethan B Ludmir; Sarah J Stephens; Manisha Palta; Christopher G Willett; Brian G Czito
Journal:  J Gastrointest Oncol       Date:  2015-06

6.  High-grade acute organ toxicity and p16(INK4A) expression as positive prognostic factors in primary radio(chemo)therapy for patients with head and neck squamous cell carcinoma.

Authors:  Narges Tehrany; Julia Kitz; Margret Rave-Fränk; Stephan Lorenzen; Li Li; Stefan Küffer; Clemens F Hess; Peter Burfeind; Holger M Reichardt; Martin Canis; Tim Beissbarth; Hendrik A Wolff
Journal:  Strahlenther Onkol       Date:  2015-01-10       Impact factor: 3.621

7.  Human Papillomavirus‒Positive and ‒Negative Vulvar Squamous Cell Carcinoma Are Biologically but Not Clinically Distinct.

Authors:  Elysha Kolitz; Elena Lucas; Gregory A Hosler; Jiwoong Kim; Suntrea Hammer; Cheryl Lewis; Lin Xu; Andrew T Day; Melissa Mauskar; Jayanthi S Lea; Richard C Wang
Journal:  J Invest Dermatol       Date:  2021-10-28       Impact factor: 7.590

Review 8.  The "HPV Discussion": Effective Use of Data to Deliver Recommendations to Patients Impacted by HPV.

Authors:  Samir S Khariwala; Michael G Moore; Kelly M Malloy; Benoit Gosselin; Richard V Smith
Journal:  Otolaryngol Head Neck Surg       Date:  2015-07-28       Impact factor: 3.497

9.  Evaluation of Prexasertib, a Checkpoint Kinase 1 Inhibitor, in a Phase Ib Study of Patients with Squamous Cell Carcinoma.

Authors:  David S Hong; Kathleen Moore; Manish Patel; Stefan C Grant; Howard A Burris; William N William; Suzanne Jones; Funda Meric-Bernstam; Jeffrey Infante; Lisa Golden; Wei Zhang; Ricardo Martinez; Sameera Wijayawardana; Richard Beckmann; Aimee Bence Lin; Cathy Eng; Johanna Bendell
Journal:  Clin Cancer Res       Date:  2018-04-11       Impact factor: 12.531

Review 10.  Meet the Insidious Players: Review of Viral Infections in Head and Neck Cancer Etiology with an Update on Clinical Trials.

Authors:  Lejla Mahmutović; Esma Bilajac; Altijana Hromić-Jahjefendić
Journal:  Microorganisms       Date:  2021-05-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.